Rohto Pharmaceutical Co. Ltd Financials

Market Capitalization ¥620.31 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	22.83
Forward PE	16.27
Price to Sales TTM	¥2.23
Price to Book MRQ	¥2.52
Enterprise to Revenue	2.14
Enterprise to EBITDA	12.12

Financial Reports as of Mar. 31, 2024

Financials

Fiscal Year Ends	2024-03-31
Most Recent Quarter	2024-03-31
Profit Margin	10.91%
Operating Margin	17.01%
Return on Assets TTM	6.92%
Return on Equity TTM	12.68%

Income Statement

Revenue TTM	¥278,025,011,200
Revenue per Share TTM	¥1218.67
Quarterly Revenue Growth	11.70%
Gross Profit TTM	¥157,285,000,000
EBITDA	¥42,719,000,000
Net Income to Common TTM	¥30,328,000,512
Diluted EPS TTM	¥119.09
Quarterly Earnings Growth YoY	-6.70%

Balance Sheet

Total Cash MRQ	¥73,623,003,136
Total Cash per Share MRQ	¥322.71
Total Debt MRQ	¥
Total Debt to Equity MRQ	17.83
Current Ratio MRQ	1.77
Book Value per Share MRQ	¥1079.71

Cash Flow

Operating Cash Flow TTM	¥30,707,000,000
Levered Free Cash Flow TTM	¥30,936,000,000

4527 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	228,139,008
Float Shares	189,453,282
Avg 10 Volume	808,460
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	10.97%
% Held by Institutions	40.49%

Stock Price Summary

Beta	-0.21
Fifty Two Week Low	¥2638.00
Fifty Two Week High	¥3688.00
Fifty Two Week Change	-14.14%
Day 50 MA	¥3096.70
Day 200 MA	¥3171.37

Dividends and Splits

Forward Annual Dividend Rate	¥32.00
Forward Annual Dividend Yield	1.20%
Trailing Annual Dividend Rate	¥31.00
Trailing Annual Dividend Yield	1.16%
Payout Ratio	20.37%
Dividend Date
Ex Dividend Date	2025-03-28
Last Split Factor
Last Split Date	2022-12-29